The global Plant-Based Vaccines Market is estimated to be valued at US$ 43.7 million in 2021 and is projected to reach US$ 49.9 million by 2028, with a CAGR of XX% during the forecast period, as stated in a new report by Coherent Market Insights. Plant-based vaccines are derived from plants, offering numerous advantages such as cost-effectiveness, scalability, safety, and ease of production. ... Read more
Plant-based vaccines make use of plants as bioreactors for the production of vaccine antigens. Compared to traditional methods of vaccine production, plant-based vaccines have advantages such as low-cost production, rapid scale-up, convenient oral delivery, and lack of requirement for industrial fermentation facilities. As infectious diseases continue to pose threats globally and the need for cost-effective vaccination methods rises, plant-based vaccines offer an economically viable ... Read more
Plant-based vaccines represent an innovative class of preventive medicines that use plants as bioreactors for production of target vaccine candidates against infectious pathogens. Plant-based vaccines utilize edible plant-based expression systems to manufacture vaccine antigens that mimic infection by disease-causing microbes like viruses or bacteria, which then stimulates the immune system and protects the body against future exposures. Some of the key advantages of plant-based vaccines ... Read more
Plant-based vaccines utilize plants as bioreactors for antigens which can help stimulate human immune response. The key advantages of plant-based vaccine production are possibility of low-cost oral delivery, ease of scalability, thermostability without any cold chain requirement and rapid production. With rising prevalence of infectious diseases and emerging need for effective vaccination programs globally, alternative platforms for vaccine manufacturing are gaining prominence.
Plant-based vaccines have several advantages over traditionally produced vaccines such as ease of production, scalability, thermostability, low-cost of production and rapid response to epidemics and pandemics. These vaccines utilize plants as bioreactors to produce antigen proteins that induce protective immunity. They facilitate single-dose vaccination and needle-free administration of oral vaccines, thereby minimizing medical waste and need for trained personnel.
